• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丙氨酸羟化酶基因中R68G和R68S突变的体外表达分析

In vitro expression analysis of R68G and R68S mutations in phenylalanine hydroxylase gene.

作者信息

Zekanowsk C, Perez B, Desviat L R, Wiszniewski W, Ugarte M

机构信息

Department of Medical Genetics, National Research Institute of Mother and Child, Warszawa, Poland.

出版信息

Acta Biochim Pol. 2000;47(2):365-9.

PMID:11051201
Abstract

Phenylketonuria (PKU), an autosomal recessive disorder caused be a deficiency of hepatic phenylalanine hydroxylase (PAH), is clinically very heterogeneous. At the molecular level, more than 400 mutations in the PAH gene are known to date, which in different genotype combinations could account for biochemical and clinical variability of symptoms. In vitro expression studies on R68G and R68S mutations causing mild phenylketonuria are presented.

摘要

苯丙酮尿症(PKU)是一种由肝脏苯丙氨酸羟化酶(PAH)缺乏引起的常染色体隐性疾病,临床表现具有高度异质性。在分子水平上,迄今为止已知PAH基因有400多种突变,不同的基因型组合可能导致症状的生化和临床变异性。本文展示了对导致轻度苯丙酮尿症的R68G和R68S突变的体外表达研究。

相似文献

1
In vitro expression analysis of R68G and R68S mutations in phenylalanine hydroxylase gene.苯丙氨酸羟化酶基因中R68G和R68S突变的体外表达分析
Acta Biochim Pol. 2000;47(2):365-9.
2
Mutations in exon 3 of the PAH gene causing mild hyperphenylalaninemia.PAH基因第3外显子的突变导致轻度高苯丙氨酸血症。
Genet Test. 1999;3(3):297-9. doi: 10.1089/109065799316626.
3
[In vitro expression and structural analysis of four missense mutations (G247S, E280G, P362T, A434D) of phenylalanine hydroxylase gene].苯丙氨酸羟化酶基因四个错义突变(G247S、E280G、P362T、A434D)的体外表达及结构分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Feb;25(1):1-5.
4
Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH.苯丙酮尿症:基于苯丙氨酸羟化酶结构和功能突变表达分析的基因型-表型相关性
Hum Mutat. 2003 Apr;21(4):370-8. doi: 10.1002/humu.10198.
5
Structural interpretation of mutations in phenylalanine hydroxylase protein aids in identifying genotype-phenotype correlations in phenylketonuria.苯丙氨酸羟化酶蛋白突变的结构解释有助于确定苯丙酮尿症的基因型-表型相关性。
Eur J Hum Genet. 2000 Sep;8(9):683-96. doi: 10.1038/sj.ejhg.5200518.
6
Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations.轻度苯丙酮尿症突变中对四氢生物蝶呤反应性的潜在机制。
Hum Mutat. 2004 Nov;24(5):388-99. doi: 10.1002/humu.20097.
7
Validation of PAH genotype-based predictions of metabolic phenylalanine hydroxylase deficiency phenotype: investigation of PKU/MHP patients from Lithuania.基于苯丙酮尿症(PAH)基因型预测代谢性苯丙氨酸羟化酶缺乏表型的验证:立陶宛苯丙酮尿症/轻度高苯丙氨酸血症(PKU/MHP)患者的调查
Med Sci Monit. 2003 Mar;9(3):CR142-6.
8
The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency.在苯丙氨酸羟化酶缺乏症中,突变基因型是代谢表型的主要决定因素。
Mol Genet Metab. 1999 Sep;68(1):43-7. doi: 10.1006/mgme.1999.2886.
9
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy.意大利南部51个苯丙氨酸羟化酶缺乏症家庭中新型突变的功能和结构特征以及基因型-表型相关性
FEBS J. 2009 Apr;276(7):2048-59. doi: 10.1111/j.1742-4658.2009.06940.x.
10
Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population.西班牙苯丙酮尿症异质群体中突变基因型与生化表型的关系。
Eur J Hum Genet. 1997 Jul-Aug;5(4):196-202.

引用本文的文献

1
Protein stability and in vivo concentration of missense mutations in phenylalanine hydroxylase.苯丙氨酸羟化酶错义突变的蛋白质稳定性和体内浓度。
Proteins. 2012 Jan;80(1):61-70. doi: 10.1002/prot.23159. Epub 2011 Sep 21.
2
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.错义突变对天然状态稳定性的预测影响解释了苯丙酮尿症(一种错误折叠疾病的范例)的表型结果。
Am J Hum Genet. 2007 Nov;81(5):1006-24. doi: 10.1086/521879. Epub 2007 Oct 2.